"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
(Generic versions may still be available.)
Actisite® (tetracycline periodontal) periodontal fiber is indicated as an adjunct to scaling and root planing for reduction of pocket depth and bleeding on probing in patients with adult periodontitis.
Effectiveness of repeated fiber applications in a site has not been studied.
DOSAGE AND ADMINISTRATION
Actisite (tetracycline periodontal) periodontal fiber for 10 days is indicated as an adjunct to scaling and root planing. Repeated fiber applications have not been studied. Actisite (tetracycline periodontal) fiber should be inserted into the periodontal pocket until the pocket is filled. The length of fiber used will vary with pocket depth and contour. The fiber should be placed to closely approximate the pocket anatomy and should be in contact with the base of the pocket. An appropriate cyanoacrylate adhesive should be used to help secure the fiber in the pocket.
When placed within a periodontal pocket, Actisite (tetracycline periodontal) fiber provides continuous release of tetracycline for 10 days. At the end of 10 days of treatment, all fibers must be removed. Fibers lost before 7 days should be replaced.
Actisite (tetracycline periodontal) periodontal fiber is available in cartons containing 4 fibers and 10 fibers. Each individually packaged, yellow fiber is 23 cm (9 inches) long and contains 12.7 mg of Actisite (tetracycline periodontal) .
NDC 17314-4800-4 (4 Fiber carton)
NDC 17314-4800-1 (10 Fiber carton)
Store at controlled room temperature 15o-30oC (59o-86oF).
Caution: Federal law prohibits dispensing without prescription.
Manufactured by Last reviewed on RxList: 12/8/2004
Palo Alto, CA 94304 USA
For product information call: 1-800-ACTISITE (tetracycline periodontal)
To place an order call: 1-800-543-2577
© Procter & Gamble and ALZA Corporation 4/94
All rights reserved
This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 12/8/2004
Additional Actisite Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.